Eli Lilly seeks approval for obesity drug in the US

The company employs around 2,300 in Ireland

Eli is headquartered in the US but has a base in Kinsale, Co Cork.

Pharmaceutical company Eli Lilly plans to seek approval for its obesity drug tirzepatide in the US.

The multinational reported that the drug helped patients lose more than 20% of their weight in a late-stage clinical trial, prompting analysts to increase their peak sales estimate for the drug.